Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 2005

View Archived Issues

First milestone in Evotec and Boehringer Ingelheim GPCR collaboration

Medicago and InterveXion establish product codevelopment collaboration

Phase III data show Oracea is effective and safe in patients with rosacea

Immunomodulation induced by NBI-6024 in type 1 diabetic patients

Preclinical data presented on the antidyskinetic effects of sarizotan

Rho kinase inhibition prevents renal and cardiac tissue fibrosis

Pharmacokinetic and pharmacodynamic properties of TRU-015

Connetics to resume Extina development

Phase III study of Erbitux for head and neck cancer meets endpoints

Solvay submits DMF for cell-derived influenza vaccine

IDEA-033 enters new European phase III study

Phase I/IIa trial of BA-210 in acute spinal cord injury recommended to continue

New financing supports Somaxon pipeline development

Altus looks to phase II studies of ALTU-238

FDA Advisory Committee votes on Pulminiq

Protox receives funding to develop lung cancer drug

Merck exercises options to Vical gene delivery technology

Tracleer launched in Japan

Byetta launched for type 2 diabetes

Clinical evidence supports the use of desmoteplase in acute ischemic stroke

New data on the effects of Fibrillex in AA amyloidosis

EP-1572 shows activity as growth hormone secretagogue in healthy volunteers

Recent Icos patents cover novel treatments for fibrotic disorders

Arginine-vasopressin V1b receptor antagonists emerge from Taisho R&D

Novel antiinflammatory/analgesic agents claimed by Bayer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...